Monte Rosa Therapeutics, Inc.
GLUEUnited States
21 filed reports · 346 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
21 reports · Jun 2021 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 16 | 2,337 | Jun 2021 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 5 | 2,034 | Dec 2021 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 6, 2026 | 332 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 7, 2026 | 207 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Mar 17, 2026 | 638 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 6, 2025 | 231 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 7, 2025 | 134 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 8, 2025 | 138 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Mar 20, 2025 | 390 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 7, 2024 | 148 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 8, 2024 | 122 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 9, 2024 | 128 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Mar 14, 2024 | 369 | Open |
| FY2023 Q3 | 10-Q | Sep 30, 2023 | Nov 9, 2023 | 146 | Open |
Financial data
346 concepts · 4,371 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial340 concepts · 4,315 facts · Mar 2020 to Jul 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value32 · Mar 2020 to Jun 2026
- Net income loss32 · Mar 2020 to Jun 2026
- Stockholders equity (US GAAP)32 · Mar 2020 to Jun 2026
- Cash and cash equivalents at carrying value31 · Jun 2020 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents31 · Jun 2020 to Jun 2026
- Comprehensive income net of tax31 · Jun 2020 to Jun 2026
- Foreign currency transaction gain loss before tax31 · Jun 2020 to Jun 2026
- General and administrative expense (US GAAP)31 · Jun 2020 to Jun 2026
- Interest income expense nonoperating net31 · Jun 2020 to Jun 2026
- Nonoperating income expense31 · Jun 2020 to Jun 2026
- Operating expenses (US GAAP)31 · Jun 2020 to Jun 2026
- Operating income loss31 · Jun 2020 to Jun 2026
- Research and development expense31 · Jun 2020 to Jun 2026
- Restricted cash31 · Jun 2020 to Jun 2026
- Allocated share based compensation expense30 · Jun 2020 to Jun 2026
- Capital expenditures incurred but not yet paid30 · Sep 2020 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect30 · Sep 2020 to Jun 2026
- Defined contribution plan employer discretionary contribution amount30 · Jun 2020 to Jun 2026
- Depreciation30 · Sep 2020 to Jun 2026
- Increase decrease in accounts payable30 · Sep 2020 to Jun 2026
- Increase decrease in accrued liabilities and other operating liabilities30 · Sep 2020 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets30 · Sep 2020 to Jun 2026
- Net cash provided by used in financing activities30 · Sep 2020 to Jun 2026
- Net cash provided by used in investing activities30 · Sep 2020 to Jun 2026
Product1 concepts · 42 facts · Mar 2024 to Jun 2026
- MRT-235942 · Mar 2024 to Jun 2026
Geography5 concepts · 14 facts · Sep 2022 to Mar 2026
- 645 Summer Street4 · Sep 2022 to Mar 2023
- Switzerland4 · Dec 2024 to Mar 2026
- Hochbergerstrasse3 · Dec 2022 to Mar 2023
- Income tax paid state and local after refund received2 · Dec 2024 to Dec 2025
- Increase decrease in operating lease liability1 · Mar 2026
Segments
56 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service5 members · 42 facts
- MRT Six One Six Zero12 · Mar 2024 to Jun 2026
- MRT Two Three Five Nine12 · Mar 2024 to Jun 2026
- MRT Eight One Zero Two11 · Jun 2024 to Jun 2026
- CCNE One4 · Mar 2025 to Jun 2026
- NEK Seven3 · Mar 2024 to Mar 2025
Statement geographical4 members · 14 facts
- Six Hundred Forty Five Summer Street7 · Sep 2022 to Mar 2023
- CH4 · Dec 2024 to Mar 2026
- MA2 · Dec 2024 to Dec 2025
- Klybeckstrasse Lease1 · Mar 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.